(assuming that the ACB Membership List reflects the composition of the specialty and that the date of joining the ACB is a rough indication of the date of entry into the specialty). This apparent fall may be due in part to a recent overabundance of young science graduates entering clinical biochemistry. Since 1965 the proportion of medical graduates entering has remained constant, about 16 %. Many others (eg, Carter et al, 1974; Alberti et al, 1975; Astrup, 1975; Lancet, 1975; Jarett, 1975) have drawn attention to problems arising from the changing nature of clinical biochemistry and have proposed solutions which involve an increase in interaction between the laboratory and clinicians, and a necessary role for medical graduates in the specialized) . In addition, the background ofa clinical chemist is such that he is more likely to find the investigation of chemical, technical or methodological problems in the laboratory satisfying as a lifetime interest. I think the strongest case for the chemical pathologist is that he is necessary for the specialty as a whole. Clinical biochemistry is a specialty of enormous scope which should include technicians, chemists, biochemists, engineers, computer experts, and medical graduates, each with something to contribute. The special function of the medical graduate is to act as a link between the patient and the specialty, acting to some extent as both physician and biochemist.
The environment in which the chemical pathologist works has changed remarkably in the past 15 years. Now, departments are to a large extent small factories producing measurements which are demanded by doctors. Much of the effort within laboratories is necessarily concerned with efficiency, accuracy, and precision, with little true consultation with clinicians and often (because of limited time and staff) little effort to assess the uses to which their measurements are put. There is, I believe, a need for some tests to be available on demand, but also, to my mind, there is a need for the extension of consultative and investigative services to the wards and to general practice. For this we need chemical pathologists who are trained to be useful and to feel at ease in the wards.
What then can be done to attract more trainees to chemical pathology? I suggest that the nascent medical graduate, relieved at last to be in contact with patients, is not attracted to clinical biochemistry if he can see only a job as administrator and educator ahead, especially if he realizes that until he becomes a consultant he must spend seven to 10 years in positions in which he can perform neither of these functions very satisfactorily. To retreat thus from direct involvement with patients, some biochemically orientated medical graduates perhaps feel, is to discard an ability with which the state has equipped him at a present cost of £28 000 or so. For these reasons I feel that the problem of recruitment can best be approached by adding to the roles discussed above. There should be greater emphasis on the function of the chemical pathologist as a reseaich worker and as a physician.
First-class research workers may be born not made. But research is not an esoteric activity. It is simply the ability to appreciate problems, formulate experiments designed to yield a positive answei, carry them out, and report the results. The components of this process can be taught, and they are fundamental to clinical biochemistry. Science graduates with a PhD, and, to some extent, those with other degrees such as the MSc in clinical biochemistry, have had an introduction to research techniques. But few medical graduates are in situations where they are strongly guided towards an MSc or MD. (In the United Kingdom the MD is a higher research degree similar to the PhD.) I feel that research experience is very desirable for the chemical pathologist, for then he can direct research in his department, and he may have developed desirable habits of scepticism and attention to detail and a respect for the difficulties of good iesearch.
There is no fundamental reason why the primary laboratory worker should not also be a practising physician; the reverse is sometimes true, and much good biochemistry is done in Departments of Medicine. With the skills of a scientist and a clinician the chemical pathologist may develop a special area of expertise in which he acts as a consultant. Without clinical skills this is difficult to do. Because the pathologist has only limited time in which to learn and practise, this area of expertise must be smaller than that of someone who devotes his whole time to clinical medicine. It should be an area with a major biochemical component, as is appropriate to a chemical pathologist. The laboratory can benefit from this, partly because it therefore has a close association with a practising clinician, and paitly because it makes the development of an area of associated biochemical research much easier.
Having done basic training as a physician, can the graduate be attracted to chemical pathology?
The data in table I show that few younger graduates who are ACB members have obtained the MRCP diploma; in all probability, few therefore act as physicians and pathologists. Perhaps the greatest barrier to a physician coming into the clinical G. D. Calvert biochemistry laboratory is the magnitude of the changes he must take in almost all aspects of his work. He regarded himself as a skilled man; now he finds himself in a position where he can at first use very few of those skills. Previously the medical graduate dealt with the whole patient, now with just one aspect of his illness, and in most cases the patient is completely unknown to him. As well as missing personal contact with patients, and the emotional rewards this brings, he misses the necessity to make decisions and take responsibility, knowing that the aim of those who design laboratories is to eliminate as many decisions as possible, or to limit decision-taking to certain well qualified people.
How then could an alternative training programme for chemical pathologists be provided to attract more into the specialty?
The trainee should have enough clinical medicine to make him competent to look after patients, which, in practice, means that he should pass the examination for MRCP. To do this he needs at least two full years on the wards after graduation, followed by a continuing part-time commitment to some area of direct patient contact. This must involve him in direct responsibility for both diagnosis and treatment.
Each training programme would be adjusted to the needs of the individual. A possible prescription, involving cooperation between the Royal Colleges of Physicians and Pathologists, could be as follows:
The candidate for the dual postgraduate qualification MRCP, MRCPath should submit his training programme to the Royal College of Pathologists for approval before training begins. A course supervisor should be appointed. Allowance may be made for training already undertaken towards either qualification.
The minimum training period is five years after the preregistration year. The candidate should spend substantially the whole of the first two years in the wards. About half this time should ideally be in general medicine, and half in areas with a strong metabolic component. During these two years the trainee should begin to attain familiarity with laboratory procedures. During this time he will be expected to take the MRCP, in which questions will be slanted towards metabolic medicine.
For the last three years of this training period, having taken the MRCP, the candidate will be expected to spend most of his time at the bench. He will be encouraged to carry out some research project in an area of laboratory medicine. His findings (description of work, published papers, thesis or other documentation) should be submitted to the Royal College of Pathologists at the end of his training period and will be taken into account when the award of the MRCPath is considered.
During this time at the bench the candidate will be expected to maintain clinical contacts through attendance on ward rounds, teaching sessions, and perhaps a research project. In addition, he should have direct responsibility for patients, for example, in an outpatient clinic or in a metabolic unit, as well as the more usual and generally accepted responsibilities of a registrar or senior registrar in the laboratory. These latter should include liaison and advisory duties with clinical staff, and, at some time, responsibility fol an area of the routine laboratory at senior biochemist level.
At the end of the training period a report from the supervisor will be assessed by the Royal College of Pathologists. The assessment will be taken into account when the award of the MRCPath is considered. In this way it is hoped that suitable candidates will be encouraged to attain some competence in clinical medicine and research in addition to the basic skills required of a chemical pathologist.
If this scheme is to be successful it must be made clear that there is not an excessive examination burden on the candidate, and that credit for appropriate clinical and research training will be given. For these reasons I have suggested a course supervisor who will advise the candidate throughout the training period. The course supervisor's report on the candidate (including reports from the heads of other departments involved in training), and a report from the candidate on his own research work, should carry considerable weight at the College of Pathologists' assessment for the MRCPath. The earlier examination for MRCP should be constructed to test the capabilities of a clinically orientated chemical pathologist, and the emphasis should therefore be on the diagnosis and treatment of diseases with a metabolic component rather than, for instance, a detailed knowledge of peripheral nerve distribution or congenital heart disease.
The 
